Methscopolamine / Pseudoephedrine Side Effects
Applies to methscopolamine/pseudoephedrine: oral tablet extended release.
Cardiovascular adverse events
Cardiovascular side effects have included cardiac palpitations. In general, sympathomimetics have been associated with tachycardia, arrhythmias, and cardiovascular collapse with hypotension.[Ref]
Nervous system
Nervous system side effects have included drowsiness, lassitude, increased irritability and excitement (especially in children). Other side effects associated with sympathomimetic amines have included headache, dizziness, anxiety, fear, nervousness, restlessness, tremor, weakness, insomnia, hallucinations, convulsions, and CNS depression.
Antihistamines and anticholinergic drugs side effects have included drowsiness and dizziness.[Ref]
Gastrointestinal
Gastrointestinal side effects have included nausea and excessive dryness of the mouth, nose and throat.[Ref]
Ocular
Ocular side effects have included blurred vision.[Ref]
Genitourinary
Genitourinary side effects associated with the used of sympathomimetic amines have included dysuria and urinary retention in patients with prostatic hypertrophy.[Ref]
Respiratory
Respiratory side effects associated with the use of sympathomimetics have included respiratory difficulty.[Ref]
References
1. (2002) "Product Information. PSE 120/MSC 2.5 (methscopolamine-pseudoephedrine)." Cypress Pharmaceutical Inc (a division of Currax Pharmaceuticals)
More about methscopolamine / pseudoephedrine
- Check interactions
- Compare alternatives
- Dosage information
- During pregnancy
- Drug class: upper respiratory combinations
Related treatment guides
Further information
Methscopolamine/pseudoephedrine side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Note: Medication side effects may be underreported. If you are experiencing side effects that are not listed, submit a report to the FDA by following this guide.